Uploaded September 2025 | Updated September 2026, 3 days ago
In this episode of EASD TV, host Vivienne Parry sits down with Prof. Gerald "Jerry" Shulman, recipient of the 11th EASD-Novo Nordisk Foundation Diabetes PRize for Excellence prize, to explore his four decades of groundbreaking research into the molecular basis of insulin resistance.
From the discovery of diacylglycerols as key drivers of insulin resistance to the development of novel mitochondrial-targeting therapies now in clinical trials, this conversation highlights a potential paradigm shift: treating insulin resistance as a central target in the same way we treat hypertension or high cholesterol.
Discover how fat buildup in cells drives type 2 diabetes, fatty liver disease, heart disease, cancers, and Alzheimer’s - and how new therapies targeting the mitochondria could transform treatment.
#DiabetesCare #InsulinResistance #MetabolicHealth
In this episode of EASD TV, host Vivienne Parry sits down with Prof. Gerald "Jerry" Shulman, recipient of the 11th EASD-Novo Nordisk Foundation Diabetes PRize for Excellence prize, to explore his four decades of groundbreaking research into the molecular basis of insulin resistance.
From the discovery of diacylglycerols as key drivers of insulin resistance to the development of novel mitochondrial-targeting therapies now in clinical trials, this conversation highlights a potential paradigm shift: treating insulin resistance as a central target in the same way we treat hypertension or high cholesterol.
Discover how fat buildup in cells drives type 2 diabetes, fatty liver disease, heart disease, cancers, and Alzheimer’s - and how new therapies targeting the mitochondria could transform treatment.
#DiabetesCare #InsulinResistance #MetabolicHealth
